Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000648366 | SCV000770182 | likely pathogenic | Neuropathy, hereditary sensory and autonomic, type 1C | 2019-11-26 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this missense change alters protein function in-vitro (PMID: 20920666, 24175284, 26681808). This variant has been reported in individuals affected with hereditary sensory and autonomic neuropathy (PMID: 20920666). ClinVar contains an entry for this variant (Variation ID: 4797). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with valine at codon 382 of the SPTLC2 protein (p.Gly382Val). The glycine residue is moderately conserved and there is a moderate physicochemical difference between glycine and valine. |
Institute of Medical Genetics and Applied Genomics, |
RCV001268055 | SCV001446663 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000648366 | SCV000025240 | pathogenic | Neuropathy, hereditary sensory and autonomic, type 1C | 2010-10-08 | no assertion criteria provided | literature only |